Brain tumor treatment increases the number of cancer stem-like cells

Expert Review of Neurotherapeutics

Volumn 9, Issue 10, 2009, Pages 1447-1449

  Charles, Nikki ^a   Holland, Eric C ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CARMUSTINE; CD133 ANTIGEN; ETOPOSIDE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PACLITAXEL; TEMOZOLOMIDE;

CANCER CHEMOTHERAPY; CANCER STEM CELL; CANCER SURGERY; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; EDITORIAL; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; IONIZING RADIATION; MEDULLOBLASTOMA;

BRAIN NEOPLASMS; CELL PROLIFERATION; COMBINED MODALITY THERAPY; HUMANS; NEOPLASTIC STEM CELLS;

EID: 70350140357     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.91     Document Type: Editorial

References (10)

1. Kang MK, Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16(5), 837-847 (2007).
2. Liu G, Yuan X, Zeng Z et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5, 67 (2006). (Pubitemid 44942887)
3. Salmaggi A, Boiardi A, Gelati M et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54(8), 850-860 (2006). (Pubitemid 44671990)
4. Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120), 756-760 (2006). (Pubitemid 44949604)
5. Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev. 22(4), 436-448 (2008). (Pubitemid 351272752)
6. Bleau AM, Hambardzumyan D, Ozawa T et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4(3), 226-235 (2009).
7. Kitange GJ, Carlson BL, Schroeder MA et al. Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro. Oncol. 11(3), 281-291 (2009).
8. Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas. Neoplasia 8(12), 1072-1082 (2006).
9. Fan X, Matsui W, Khaki L et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66(15), 7445-7452 (2006). (Pubitemid 44289197)
10. Wang Z, Li Y, Kong D et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res. 69(6), 2400-2407 (2009).